or to vote comment and more!
“Nurse practitioners and physician assistants are an integral part of medical practices and are involved in patient care, diagnosis, and prescribing medicine,” Cannabis Regulatory Commission Executive Director Jeff Brown told the news outlet. “We are excited to implement the process for them to participate in the program to provide greater access to patients and to make the process more efficient for care provider offices.”
The change is part of Jake Honig’s law, which expanded New Jersey’s medical cannabis program and has been rolled out over the course of the last two years.
On July 2, 2019, Gov. Phil Murphy signed the Jake Honig Compassionate Use Medical Cannabis Act into law. The law set a new foundation for New Jersey’s medical cannabis program — one that is patient centered, compassionate, and scientifically focused. Since the beginning of the Murphy Administration — when only 17,000 patients were enrolled — the program has enrolled 63,000 new patients for a total of 80,000 New Jersey residents who are getting the help they need.
To ensure qualifying patients acquire medicinal marijuana safely and reduce trips to Alternative Treatment Centers (ATCs) during the state’s COVID-19 response and beyond, the New Jersey Department of Health today issued a waiver that allows ATCs to provide home delivery of medical cannabis to patients and designated caregivers. This marks a significant first step in implementing the full home delivery provisions found in Jake Honig’s Law, which was signed by Governor Murphy last summer.
The sales tax on medical marijuana will drop to 4% from its current 6.625% on July 1, part of a phased elimination of the levy that was embodied in the 2019 redo of the state’s medical cannabis system called the Jake Honig Compassionate Use Medical Cannabis Act.
Under the measure, billed as a sweeping reform New Jersey’s Medicinal Marijuana Program to expand patient access to medical marijuana, the rate will drop to 2% as of July 1, 2021, and then to zero as of July 2022.
When an Amazon employee in Edison with a medical cannabis card tried to inform his employer that he would fail a drug test due to his prescription, the company allegedly had him take it anyway and fired him for failing it, according to a suit filed in November. A funeral director in Linden was allegedly terminated in 2016 after his employer learned he was prescribed medical cannabis to treat cancer symptoms.
The employer argued that the workers’ compensation order to reimburse Hager for his medical marijuana violated the federal Controlled Substances Act (“CSA”), which criminalizes the possession, manufacture, or distribution of marijuana and therefore preempts New Jersey’s Jake Honig Compassionate Use Medical Cannabis Act (“Jake Honig Act”). The employer further argued that the order required it to aid and abet the employee’s illegal use and possession of marijuana in violation of the CSA.
On July 2, 2019, New Jersey Governor Phil Murphy signed Assembly Bill 20 (AB 20 or the Act). AB 20’s expansion of New Jersey’s current medical cannabis program includes: